Showing results (171-180 of 6,006) with videos related to

Sort By:
Pageof 601
Molecular Cancer Therapeutics|August 28, 2020
Pharmacologic Properties and Preclinical Activity of Sasanlimab, A High-affinity Engineered Anti-Human PD-1 AntibodyAmir A Al-Khami, Sawsan Youssef, Yasmina Abdiche, et al.
Molecular Cancer Therapeutics|July 13, 2019
Aberrant Expression of ERG Promotes Resistance to Combined PI3K and AR Pathway Inhibition through Maintenance of AR Target GenesNinghui Mao, Dong Gao, Wenhuo Hu, et al.
Molecular Cancer Therapeutics|October 16, 2004
Novel single-stranded oligonucleotides that inhibit signal transducer and activator of transcription 3 induce apoptosis in vitro and in vivo in prostate cancer cell linesBeverly E Barton, Thomas F Murphy, Ping Shu, et al.
Molecular Cancer Therapeutics|October 16, 2004
Sensitization of a human ovarian cancer cell line to temozolomide by simultaneous attenuation of the Bcl-2 antiapoptotic protein and DNA repair by O6-alkylguanine-DNA alkyltransferaseVincent A Barvaux, Paul Lorigan, Malcolm Ranson, et al.
Molecular Cancer Therapeutics|October 16, 2004
G2 cell cycle arrest, down-regulation of cyclin B, and induction of mitotic catastrophe by the flavoprotein inhibitor diphenyleneiodoniumRobin M Scaife
Molecular Cancer Therapeutics|October 16, 2004
Cells resistant to HTI-286 do not overexpress P-glycoprotein but have reduced drug accumulation and a point mutation in alpha-tubulinFrank Loganzo, Malathi Hari, Tami Annable, et al.
Molecular Cancer Therapeutics|October 16, 2004
Targeting ErbB receptor signaling: a pan-ErbB approach to cancerCarolyn D Britten
Molecular Cancer Therapeutics|November 16, 2004
Discovery and mechanism of action of a novel series of apoptosis inducers with potential vascular targeting activityShailaja Kasibhatla, Henriette Gourdeau, Karen Meerovitch, et al.
Molecular Cancer Therapeutics|November 16, 2004
Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: antisense down-regulation of exon 5 alters target gene expression and inhibits cell survivalJane Renshaw, Rosanne M Orr, Michael I Walton, et al.
Molecular Cancer Therapeutics|January 20, 2005
Preclinical studies of a nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-X(L) [(-)-gossypol] against diffuse large cell lymphomaRamzi M Mohammad, Shaomeng Wang, Amro Aboukameel, et al.
Pageof 601